Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
2021
Biodiversity, Natural Capital and the Economy: A Policy Guide for Finance, Economic and Environment Ministers
Esta guía política, preparada por la OCDE a petición de la Presidencia británica del G7, está destinada a los dirigentes…
Science Based Targets for Nature. An overview for companies
There is a deep understanding of the clear scientific evidence that reaching net zero emissions will not be possible without…
Banking on Biodiversity Collapse: Forest-risk Finance Trends and Policy Recommendations
Este informe analiza cómo los flujos financieros hacia sectores de riesgo forestal (soja, palma, carne bovina, pulpa y papel, caucho…